295 related articles for article (PubMed ID: 33835000)
1. Plexiform Neurofibroma Without Neurofibromatosis Type 1.
Wollina U; Schönlebe J
Acta Dermatovenerol Croat; 2020 Dec; 28(7):245-246. PubMed ID: 33835000
[TBL] [Abstract][Full Text] [Related]
2. Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
Varin J; Poulain L; Hivelin M; Nusbaum P; Hubas A; Laurendeau I; Lantieri L; Wolkenstein P; Vidaud M; Pasmant E; Chapuis N; Parfait B
Oncotarget; 2016 Jun; 7(24):35753-35767. PubMed ID: 26840085
[TBL] [Abstract][Full Text] [Related]
3. A brief report of plexiform neurofibroma.
Khajavi M; Khoshsirat S; Ahangarnazari L; Majdinasab N
Curr Probl Cancer; 2018; 42(2):256-260. PubMed ID: 29449010
[TBL] [Abstract][Full Text] [Related]
4. ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors.
Friedrich RE; Nörnberg LKN; Hagel C
Anticancer Res; 2022 May; 42(5):2327-2340. PubMed ID: 35489721
[TBL] [Abstract][Full Text] [Related]
5. The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1.
Gesundheit B; Parkin P; Greenberg M; Baruchel S; Senger C; Kapelushnik J; Smith C; Klement GL
J Pediatr Hematol Oncol; 2010 Oct; 32(7):548-53. PubMed ID: 20686424
[TBL] [Abstract][Full Text] [Related]
6. 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
Fisher MJ; Belzberg AJ; de Blank P; De Raedt T; Elefteriou F; Ferner RE; Giovannini M; Harris GJ; Kalamarides M; Karajannis MA; Kim A; Lázaro C; Le LQ; Li W; Listernick R; Martin S; Morrison H; Pasmant E; Ratner N; Schorry E; Ullrich NJ; Viskochil D; Weiss B; Widemann BC; Zhu Y; Bakker A; Serra E
Am J Med Genet A; 2018 May; 176(5):1258-1269. PubMed ID: 29681099
[TBL] [Abstract][Full Text] [Related]
7. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment.
Attia S; Guirguis M; Le LQ; Chhabra A
Skeletal Radiol; 2024 Apr; 53(4):769-777. PubMed ID: 37903998
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Morphological and Immunohistochemical Study.
Friedrich RE; Nörnberg LKN; Hagel C
Anticancer Res; 2022 Mar; 42(3):1247-1261. PubMed ID: 35220215
[TBL] [Abstract][Full Text] [Related]
9. [Rare form of a segmental neurofibromatosis with giant plexiform neurofibroma].
Reschke R; Kadlecova M; Grunewald S; Ziemer M
Hautarzt; 2019 Aug; 70(8):638-640. PubMed ID: 31076816
[TBL] [Abstract][Full Text] [Related]
10. Size of tooth crowns and position of teeth concerning the extension of facial plexiform neurofibroma in patients with neurofibromatosis type 1.
Friedrich RE; Giese M; Stelljes C; Froeder C; Scheuer HA
Anticancer Res; 2012 May; 32(5):2207-14. PubMed ID: 22593511
[TBL] [Abstract][Full Text] [Related]
11. Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases.
McCarron KF; Goldblum JR
Mod Pathol; 1998 Jul; 11(7):612-7. PubMed ID: 9688181
[TBL] [Abstract][Full Text] [Related]
12. Current status of MEK inhibitors in the treatment of plexiform neurofibromas.
Gross AM; Dombi E; Widemann BC
Childs Nerv Syst; 2020 Oct; 36(10):2443-2452. PubMed ID: 32607696
[TBL] [Abstract][Full Text] [Related]
13. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
Nishida Y; Ikuta K; Ito S; Urakawa H; Sakai T; Koike H; Ito K; Imagama S
Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792
[TBL] [Abstract][Full Text] [Related]
14. Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1.
Friedrich RE; Tuzcu CT
In Vivo; 2021; 35(2):889-905. PubMed ID: 33622881
[TBL] [Abstract][Full Text] [Related]
15. Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R
Curr Oncol Rep; 2023 Dec; 25(12):1409-1417. PubMed ID: 37906356
[TBL] [Abstract][Full Text] [Related]
16. Plexiform neurofibroma with nevus of ota-rare presentation.
Taneja L; Dokwal SK; Prajapat J; Arya V
J Oral Maxillofac Pathol; 2021; 25(2):374. PubMed ID: 34703146
[TBL] [Abstract][Full Text] [Related]
17. Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells.
Mazuelas H; Carrió M; Serra E
Stem Cell Res; 2020 Dec; 49():102068. PubMed ID: 33160273
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous plexiform schwannoma associated with neurofibromatosis type 2.
Val-Bernal JF; Figols J; Vázquez-Barquero A
Cancer; 1995 Oct; 76(7):1181-6. PubMed ID: 8630895
[TBL] [Abstract][Full Text] [Related]
19. Malignant Peripheral Nerve Sheath Tumor Arising Within Lumbar Spinal Plexiform Neurofibroma.
Alves Júnior SF; Pessoa Corrêa JA; Marchiori E
World Neurosurg; 2019 Oct; 130():264-266. PubMed ID: 31323411
[TBL] [Abstract][Full Text] [Related]
20. A case of isolated giant plexiform neurofibroma involving all branches of the common peroneal nerve.
Cebesoy O; Tutar E; Isik M; Arpacioglu O
Arch Orthop Trauma Surg; 2007 Oct; 127(8):709-12. PubMed ID: 17377797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]